½ÃÀ庸°í¼­
»óǰÄÚµå
1579369

¼¼°èÀÇ µ¿¹°¿ë ÆéÅæ ½ÃÀå : À¯Çü, µî±Þ, Çü»ó, °ø±Þ¿ø, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Animal Peptone Market by Type (Casein peptone, Collagen peptone), Grade (Industrial Grade, Pharmaceutical Grade, Research Grade), Form, Source, Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

µ¿¹°¿ë ÆéÅæ ½ÃÀåÀº 2023³â¿¡ 1¾ï 2,943¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 1¾ï 3,870¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.67%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 1,716¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µ¿¹°¼º ÆéÅæÀº µ¿¹°¼º ´Ü¹éÁúÀÇ È¿¼Ò °¡¼öºÐÇØ ¶Ç´Â »ê °¡¼öºÐÇØ·ÎºÎÅÍ ¾ò¾îÁö´Â °ÍÀ¸·Î, ½ÇÇè½ÇÀ̳ª °ø¾÷¿ëµµ·Î ¹Ì»ý¹°À» ¹è¾çÇϱâ À§ÇÑ ¹èÁö¸¦ ¸¸µå´Âµ¥ À־ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. µ¿¹°¼º ÆéÅæÀº ÀǾàǰ, ½Äǰ ¹ßÈ¿, Áø´Ü µî ´Ù¾çÇÑ »ý¸í°øÇÐ °úÁ¤¿¡ ÇʼöÀûÀÔ´Ï´Ù. µ¿¹°¼º ÆéÅæÀÇ Çʿ伺Àº ¹ÚÅ׸®¾Æ ¹è¾çÀÇ ¼ºÀåÀ» º¸ÀåÇÏ°í ¹é½Å, Ç×»ýÁ¦ ¹× ±âŸ »ý¹°ÇÐÀûÀ¸·Î Áß¿äÇÑ ¹°ÁúÀÇ »ý»êÀ» ÃÖÀûÈ­ÇÏ´Â ¿ªÇÒ¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ±× ¿ëµµ´Â ´Ù¾çÇϸç Áø´Ü ½Ã¾à Á¦Á¶, ¹é½Å ¼ºÀå ÃËÁø ¹× ±âŸ Ä¡·á »ý¹°ÇÐÀû Á¦Á¦ÀÇ Á¦Á¶¿¡ ¸Å¿ì Áß¿äÇÑ ÀÇ·á ºÐ¾ßµµ Æ÷ÇԵ˴ϴÙ. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶, Çмú±â°ü ¹× ¿¬±¸±â°ü, ½ÄÀ½·á »ê¾÷ µîÀÇ »ê¾÷¿¡ À̸¨´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 1¾ï 2,943¸¸ ´Þ·¯
¿¹Ãø³â(2024) 1¾ï 3,870¸¸ ´Þ·¯
¿¹Ãø³â(2030) 2¾ï 1,716¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.67%

ÇöÀç ½ÃÀå Á¶»ç¿¡¼­´Â »ý¸í°úÇÐ ºÐ¾ßÀÇ ¿¬±¸È°µ¿ÀÌ È°¹ßÇØÁü¿¡ µû¶ó »ý¸í°øÇÐ ¹× Á¦¾à¾÷°èÀÇ Áøº¸°¡ ¼ö¿ä Áõ°¡¸¦ À̲ø¾î °¡°í ÀÖÀ½À» ÁöÀûÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ±¹°¡¿¡¼­ÀÇ ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷ÀÇ ¼ºÀå ¼öÁذú ¼¼°è ¿¬±¸ °³¹ßºñ Áõ°¡°¡ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÆéÅæ Á¦ÇüÀÇ °³¼±¿¡´Â »õ·Î¿î ±ÕÁÖ ¹× º¯ÇüµÈ À¯ÀüÀÚ ±¸Á¶¿¡ ƯÀÌÀûÀ¸·Î ÀûÀÀÇÒ ¼ö ÀÖ´Â ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. »ý¸í°øÇÐ ºÎ¹®ÀÇ È®´ë´Â ƯÈ÷ °³ÀÎÈ­µÈ ÀÇ·á ¹× Ã·´Ü Ä¡·á ¼Ö·ç¼Ç¿¡¼­ °ß°íÇÑ Àü¸ÁÀ» º¸¿©ÁÖ¸ç ¼ºÀåÀ» À§ÇÑ À¯¸®ÇÑ ±æÀ» Á¦½ÃÇÕ´Ï´Ù. ±×·¯³ª µ¿¹° À¯·¡ Á¦Ç°¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á, »ý»ê ºñ¿ëÀÇ ³ôÀÌ, ±ÔÁ¦ ¿ä°ÇÀÇ ¾ö°ÝÇÔ µîÀÇ °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½Ä¹° À¯·¡ÀÇ ÆéÅæÀ» °³¹ßÇϰųª µ¿¹° À¯·¡ÀÇ °ÍÀ» º¸´Ù Áö¼Ó °¡´ÉÇϰí À±¸®ÀûÀ¸·Î ½ÇÇà °¡´ÉÇÑ °Í¿¡ ÃÖÀûÈ­ÇÏ´Â µ¥ ÁßÁ¡À» µÐ ±â¼ú Çõ½ÅÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ¿¬±¸´Â ¼öÀ² Çâ»ó, »ý»ê ºñ¿ë Àý°¨, ¿À¿°¹°ÁúÀÌ ¾ø´Â º¸´Ù ¼ø¼öÇÑ Á¦Ç° ÇüÅÂÀÇ »ý¼ºÀ» ´Ù·ç¾î¾ß ÇÕ´Ï´Ù. ÁÖ¿ä ±â¼ú Çõ½ÅÀº Àç¹è°¡ ¾î·Á¿î ¹Ì»ý¹° Á¾ÀÇ ¹è¾çÀ¸·Î À̾îÁú ¼ö ÀÖÀ¸¹Ç·Î ÀÀ¿ë ºÐ¾ß°¡ ³Ð¾îÁý´Ï´Ù. ÇöÀç ½ÃÀåÀº ±â¼úÀûÀ¸·Î °íµµ·Î Áö¼Ó °¡´ÉÇÑ Á¦Ç° ¶óÀÎÀ» Çõ½ÅÇÏ´Â ¼±µµ ±â¾÷°ú°æÀï ±¸µµ¸¦ Ư¡À¸·ÎÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ±â¼ú¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ¿Í Çмú ¿¬±¸¿ÍÀÇ ¿¬°è¸¦ ÅëÇØ µ¿¹° ÆéÅæ À̿뿡 »õ·Î¿î ÆÐ·¯´ÙÀÓÀ» ¹ß±¼ÇÏ¿© ½ÃÀå ¼ºÀå°ú ÃÖ÷´Ü Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â µ¿¹° ÆéÅæ ½ÃÀå¿¡¼­ Áß¿äÇÑ ½ÃÀå ÀλçÀÌÆ®ÀÇ ÇØ¸í

µ¿¹° ÆéÅæ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • µ¿¹°¿ë ÆéÅæÀ» Ȱ¿ëÇÑ ½ÄÀ½·á, À¯Á¦Ç°, ¿µ¾çº¸Á¶½Äǰ µî ÃÖÁ¾¿ëµµ»ê¾÷ÀÇ ¼ºÀå
    • ½Ä¹° À¯·¡ÀÇ ÇÕ¼º ÆéÅæÀ» ´ë½ÅÇÏ´Â Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ ´ëüǰÀ¸·Î¼­ÀÇ µ¿¹°¿ë ÆéÅæÀÇ Ã¤¿ë
    • ÀǾàǰ Á¦Á¶ °øÁ¤ °³¼±À» À§ÇÑ ÀǾàǰ¿¡ À־ÀÇ µ¿¹°¿ë ÆéÅæÀÇ »ç¿ë È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • µ¿¹°¿ë ÆéÅæ Á¦Ç°ÀÇ »ç¿ë¿¡ µû¸¥ ¾Ë·¹¸£±â¼º À§Çè
    • Á¦Á¶, ÃßÃâ ºñ¿ëÀÇ ³ôÀÌ¿¡ ÀÇÇÑ °¡°ÝÀÇ »ó½Â°ú °¡°Ý°æ°¨ÀÇ ÀúÇÏ
  • ½ÃÀå ±âȸ
    • ¼öÀ² Áõ°¡¿Í ºñ¿ë Àý°¨À» ¸ñÀûÀ¸·Î ÇÑ ¹èÁö ó¹æÀÇ ÃÖÀûÈ­¸¦ ¸ñÇ¥·Î ÇÑ Çõ½Å
    • Çмú±â°ü, ¿¬±¸±â°ü, ¹ÙÀÌ¿ÀÀǾàǰ±â¾÷°úÀÇ Á¦ÈÞ
  • ½ÃÀåÀÇ °úÁ¦
    • µ¿¹°¿ë ÆéÅæ Á¦Ç°ÀÇ ±ÕÀϼº°ú Àϰü¼ºÀ» À¯ÁöÇϴµ¥ À־ °úÁ¦°¡ µÇ´Â ¼¼°è Ç¥ÁØÀÇ ÆíÂ÷
    • µ¿¹°º¹Áö¿Í µ¿¹°À¯·¡Á¦Ç° »ç¿ëÀÇ À±¸®Àû Àǹ̿¡ ´ëÇÑ »çȸÀû ¿ì·Á

Porter's Five Forces : µ¿¹° ÆéÅæ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µ¿¹° ÆéÅæ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µ¿¹° ÆéÅæ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® µ¿¹° ÆéÅæ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

µ¿¹° ÆéÅæ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Positioning Matrix µ¿¹° ÆéÅæ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µ¿¹° ÆéÅæ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ µ¿¹° ÆéÅæ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

µ¿¹° ÆéÅæ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • µ¿¹°¿ë ÆéÅæÀ» Ȱ¿ëÇÑ ½Äǰ ¹× À½·á, À¯Á¦Ç°, ¿µ¾ç º¸Á¶ ½Äǰ µîÀÇ ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ¼ºÀå
      • ½Ä¹° À¯·¡ ¹× ÇÕ¼º ÆéÅæÀÇ Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ ´ëüǰÀ¸·Î¼­ÀÇ µ¿¹°¿ë ÆéÅæÀÇ Ã¤¿ë
      • ÀǾàǰ Á¦Á¶ °øÁ¤ÀÇ °³¼±À» À§ÇØ, ÀǾàǰ¿¡ À־ÀÇ µ¿¹°¿ë ÆéÅæÀÇ »ç¿ëÀÌ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • µ¿¹°¿ë ÆéÅæ Á¦Ç°ÀÇ »ç¿ë°ú °ü·ÃµÈ ¾Ë·¹¸£±â À§Çè
      • »ý»ê ºñ¿ë°ú ÃßÃâ ºñ¿ëÀÇ »ó½ÂÀ¸·Î °¡°ÝÀÌ »ó½ÂÇÏ¿© ±¸ÀÔÇϱ⠾î·Á¿öÁø´Ù
    • ±âȸ
      • ¹è¾ç ¹èÁö ¹èÇÕÀÇ ÃÖÀûÈ­¸¦ ¸ñÇ¥·Î ÇÑ Çõ½Å¿¡ ÀÇÇØ ¼ö·®À» ´Ã·Á ÄÚ½ºÆ®¸¦ »è°¨
      • Çмú±â°ü, ¿¬±¸±â°ü, ¹ÙÀÌ¿ÀÀǾàǰ±â¾÷°úÀÇ Á¦ÈÞ
    • °úÁ¦
      • ´Ù¾çÇÑ ¼¼°è Ç¥ÁØ¿¡ µû¶ó µ¿¹° ÆéÅæ Á¦Ç°ÀÇ Àϰü¼º°ú Àϰü¼ºÀ» À¯ÁöÇÏ´Â °ÍÀÌ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù.
      • µ¿¹° º¹Áö¿Í µ¿¹° À¯·¡ Á¦Ç°ÀÇ »ç¿ëÀÇ À±¸®Àû ¿µÇâ¿¡ °üÇÑ ±¹¹ÎÀÇ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • À¯Çü : ÀǾàǰ, »ý¸í°øÇÐ, È­Àåǰ¿¡¼­ Ä«Á¦Àΰú Äݶó°Õ ÆéÅæÀÇ Áß¿äÇÑ ¿ªÇÒÀÌ ½ÃÀåÀÇ ¼ºÀå°ú Çõ½ÅÀ» ÃßÁø
    • Ŭ·¡½º : ºñ¿ë È¿À²¼º, ´ë·® ÀÔ¼ö¼º, Àϰü¼ºÀ¸·Î »ê¾÷¿ë ±Þ·áÀÇ ÆéÅæ ¼ö¿ä°¡ ±ÞÁõ
    • ÇüÅ : À¯¿¬¼º, ºñ¿ë È¿À², º¸Á¸ ±â°£ÀÇ ¿¬ÀåÀÇ ÀÌÁ¡¿¡ ÀÇÇØ ºÐ¸»»óÀÇ µ¿¹°¿ë ÆéÅæÀÌ ¼±È£µÇ´Â °æÇâÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
    • Ãâó : °í´Ü¹éÁú ÇÔÀ¯·®°ú Á¾ÇÕÀûÀÎ ¾Æ¹Ì³ë»ê ÇÁ·ÎÆÄÀÏ¿¡ ÀÇÇØ ÀǾàǰ ¹× »ê¾÷ ¹Ì»ý¹°Çп¡ À־ÀÇ ¼Ò ÆéÅæÀÇ Ã¤¿ëÀÌ Áõ°¡
    • ÀÀ¿ë : »ý¸í°øÇÐ, ÀǾàǰ, »ê¾÷ ¹ßÈ¿¿¡ À־ÀÇ µ¿¹°¿ë ÆéÅæÀÇ ´Ù¾çÇÑ ÀÀ¿ëÀÇ Å½±¸
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå µ¿¹°¿ë ÆéÅæ ½ÃÀå : À¯Çüº°

  • Ä«Á¦ÀÎ ÆéÅæ
  • Äݶó°Õ ÆéÅæ

Á¦7Àå µ¿¹°¿ë ÆéÅæ ½ÃÀå : µî±Þº°

  • °ø¾÷ µî±Þ
  • ÀǾàǰ µî±Þ
  • Á¶»ç µî±Þ

Á¦8Àå µ¿¹°¿ë ÆéÅæ ½ÃÀå : Çüź°

  • ¾×ü
  • ºÐ¸»

Á¦9Àå µ¿¹°¿ë ÆéÅæ ½ÃÀå : ¼Ò½ºº°

  • µ¿¹°Á¦Ç°º°
    • ¼Ò
    • ¹°°í±â
    • µÅÁö°í±â
  • °í±â ÃßÃâ¹°
    • ½ÉÀå ÃßÃâ¹°
    • °£ ÃßÃâ¹°
  • ¿ìÀ¯
    • Ä«Á¦ÀÎ °¡¼öºÐÇØ¹°
    • À¯Ã» °¡¼öºÐÇØ¹°
  • È¿¸ð ÃßÃâ¹°

Á¦10Àå µ¿¹°¿ë ÆéÅæ ½ÃÀå : ¿ëµµº°

  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¿¬±¸°³¹ß
  • Áø´Ü ½Ã¾à
  • ½Äǰ, »ç·á
  • °ø¾÷ ¹ßÈ¿
  • ¹Ì»ý¹° ¹èÁö
  • ÀǾàǰ

Á¦11Àå ¾Æ¸Þ¸®Ä« µ¿¹°¿ë ÆéÅæ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µ¿¹°¿ë ÆéÅæ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µ¿¹°¿ë ÆéÅæ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • FDA°¡ Arla FoodsÀÇ À¯Ã» ´Ü¹éÁú °¡¼öºÐÇØ¹°À» À¯¾Æ¿ë Á¶Á¦À¯¿¡ ½ÂÀÎ, ¾Ë·¹¸£±â °ü¸®¿Í ÀåÀÇ ÄèÀû¼º Çâ»óÀ» ½ÇÇö
    • Lesaffre°¡ DSM-Çʸ޴ÏÈ÷ÀÇ È¿¸ð ¿¢±â½º »ç¾÷À» Àμö, dz¹Ì Á¶¹Ì·áÀÇ ¿¬±¸ °³¹ß°ú ¼¼°è Àü°³¸¦ °­È­
    • LoopwormÀº Áö¼Ó °¡´ÉÇÑ µ¿¹°¼º ´Ü¹éÁú¿øÀ¸·Î¼­ ´©¿¡¸¦ Ȱ¿ëÇϰí ÀÖ´Ù
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Alpha Teknova, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Biotecnica Inc.
  • Corning Incorporated
  • GE Healthcare
  • HiMedia Laboratories
  • Jinan Fengli Feed Co., Ltd
  • Kerry Group plc
  • Lonza Group Ltd.
  • Merck KGaA
  • MP Biomedicals, LLC
  • Neogen Corporation
  • Organotechnie SAS
  • Promega Corporation
  • Scharlab SL
  • Solabia Group
  • The Tatua Co-operative Dairy Company Ltd.
  • Thermo Fisher Scientific Inc.
  • Titan Biotech Ltd.
  • VWR International, LLC
  • ZymeFast Inc.
BJH 24.11.07

The Animal Peptone Market was valued at USD 129.43 million in 2023, expected to reach USD 138.70 million in 2024, and is projected to grow at a CAGR of 7.67%, to USD 217.16 million by 2030.

Animal peptones, derived from the enzymatic or acid hydrolysis of animal proteins, are crucial in creating culture media used for cultivating microorganisms in laboratories and industrial applications. They are essential for various biotechnology processes, including pharmaceuticals, food fermentation, and diagnostics. The necessity of animal peptones is driven by their role in ensuring the growth of bacterial cultures, optimizing the production of vaccines, antibiotics, and other biologically significant substances. Applications are diverse and include the healthcare sector, where they're pivotal for creating diagnostic reagents, fostering vaccine growth, and other therapeutic biologicals. The end-use scope extends to industries like biopharmaceutical production, academic and research institutions, and food and beverage industries.

KEY MARKET STATISTICS
Base Year [2023] USD 129.43 million
Estimated Year [2024] USD 138.70 million
Forecast Year [2030] USD 217.16 million
CAGR (%) 7.67%

Current market insights point to an increasing demand driven by advancements in biotech and pharmaceutical industries, accompanied by rising research activities in life sciences. Growing biopharmaceutical industry standards, particularly in developing countries, and the rise in global R&D expenditure are key growth influencers. Opportunities exist in enhancing peptone formulations specifically adapted to new strains or modified genetic structures of interest. The biotechnology sector's expansion presents robust prospects, particularly in personalized medicine and advanced therapeutic solutions, hinting at lucrative avenues for growth. However, challenges such as the ethical concerns over animal-based products, high costs of production, and stringent regulatory requirements can impede market growth.

Innovation is vital, focusing on developing plant-based peptones or optimizing animal-derived ones to be more sustainable and ethically viable. Research should address enhancing yields, reducing production costs, and generating purer product forms free from contaminants. Key innovations could lead to cultivating harder-to-grow microbial species, thereby widening application scopes. The current market is characterized by competitive landscapes with major firms innovating technologically advanced and sustainable product lines. Overall, strategic investments in technology and collaboration with academic research can unearth new paradigms in animal peptone utilization, fostering market growth and cutting-edge breakthroughs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Peptone Market

The Animal Peptone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth of end-use industries such as food and beverage, dairy, and nutraceuticals utilizing animal peptone
    • Adoption of animal peptone as a sustainable and eco-friendly alternative to plant-based and synthetic peptones
    • Growing use of animal peptone in pharmaceuticals for improved drug manufacturing processes
  • Market Restraints
    • Allergenicity risks associated with the use of animal peptone products
    • High production and extraction costs leading to elevated prices and reduced affordability
  • Market Opportunities
    • Innovations aimed at optimizing culture media formulations to increase yield and reduce costs
    • Collaborations with academic institutions, research organizations, and biopharmaceutical companies
  • Market Challenges
    • Varying global standards creating challenges in maintaining uniformity and consistency in animal peptone products
    • Public concerns about animal welfare and the ethical implications of using animal-derived products

Porter's Five Forces: A Strategic Tool for Navigating the Animal Peptone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Peptone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Peptone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Peptone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Peptone Market

A detailed market share analysis in the Animal Peptone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Peptone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Peptone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Peptone Market

A strategic analysis of the Animal Peptone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Peptone Market, highlighting leading vendors and their innovative profiles. These include Alpha Teknova, Inc., Becton, Dickinson and Company, bioMerieux SA, Biotecnica Inc., Corning Incorporated, GE Healthcare, HiMedia Laboratories, Jinan Fengli Feed Co., Ltd, Kerry Group plc, Lonza Group Ltd., Merck KGaA, MP Biomedicals, LLC, Neogen Corporation, Organotechnie SAS, Promega Corporation, Scharlab S.L., Solabia Group, The Tatua Co-operative Dairy Company Ltd., Thermo Fisher Scientific Inc., Titan Biotech Ltd., VWR International, LLC, and ZymeFast Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Peptone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Casein peptone and Collagen peptone.
  • Based on Grade, market is studied across Industrial Grade, Pharmaceutical Grade, and Research Grade.
  • Based on Form, market is studied across Liquid and Powder.
  • Based on Source, market is studied across Animal By-Products, Meat Extracts, Milk, and Yeast Extracts. The Animal By-Products is further studied across Bovine, Fish, and Porcine. The Meat Extracts is further studied across Heart Extracts and Liver Extracts. The Milk is further studied across Casein Hydrolysate and Whey Hydrolysate.
  • Based on Application, market is studied across Biotechnology Research & Development, Diagnostic Reagents, Food & Feed, Industrial Fermentation, Microbiological Media, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth of end-use industries such as food and beverage, dairy, and nutraceuticals utilizing animal peptone
      • 5.1.1.2. Adoption of animal peptone as a sustainable and eco-friendly alternative to plant-based and synthetic peptones
      • 5.1.1.3. Growing use of animal peptone in pharmaceuticals for improved drug manufacturing processes
    • 5.1.2. Restraints
      • 5.1.2.1. Allergenicity risks associated with the use of animal peptone products
      • 5.1.2.2. High production and extraction costs leading to elevated prices and reduced affordability
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations aimed at optimizing culture media formulations to increase yield and reduce costs
      • 5.1.3.2. Collaborations with academic institutions, research organizations, and biopharmaceutical companies
    • 5.1.4. Challenges
      • 5.1.4.1. Varying global standards creating challenges in maintaining uniformity and consistency in animal peptone products
      • 5.1.4.2. Public concerns about animal welfare and the ethical implications of using animal-derived products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type : Essential roles of casein and collagen peptones in pharmaceuticals, biotechnology, and cosmetics driving market growth and innovation
    • 5.2.2. Grade: Proliferating demand for industrial grade peptone owing to cost-effectiveness, bulk availability and consistency
    • 5.2.3. Form: Growing preference for powdered animal peptone owing to flexibility, cost-effectiveness and extended shelf-life advantages
    • 5.2.4. Source: Increased adoption of bovine peptones in pharmaceuticals and industrial microbiology owing to high protein content and and comprehensive amino acid profiles
    • 5.2.5. Application: Exploring the diverse applications of animal peptone in biotechnology, pharmaceuticals, and industrial fermentation
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Peptone Market, by Type

  • 6.1. Introduction
  • 6.2. Casein peptone
  • 6.3. Collagen peptone

7. Animal Peptone Market, by Grade

  • 7.1. Introduction
  • 7.2. Industrial Grade
  • 7.3. Pharmaceutical Grade
  • 7.4. Research Grade

8. Animal Peptone Market, by Form

  • 8.1. Introduction
  • 8.2. Liquid
  • 8.3. Powder

9. Animal Peptone Market, by Source

  • 9.1. Introduction
  • 9.2. Animal By-Products
    • 9.2.1. Bovine
    • 9.2.2. Fish
    • 9.2.3. Porcine
  • 9.3. Meat Extracts
    • 9.3.1. Heart Extracts
    • 9.3.2. Liver Extracts
  • 9.4. Milk
    • 9.4.1. Casein Hydrolysate
    • 9.4.2. Whey Hydrolysate
  • 9.5. Yeast Extracts

10. Animal Peptone Market, by Application

  • 10.1. Introduction
  • 10.2. Biotechnology Research & Development
  • 10.3. Diagnostic Reagents
  • 10.4. Food & Feed
  • 10.5. Industrial Fermentation
  • 10.6. Microbiological Media
  • 10.7. Pharmaceuticals

11. Americas Animal Peptone Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Animal Peptone Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Animal Peptone Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. FDA approves Arla Foods' whey protein hydrolysates for infant formulas, enabling better allergy management and gut comfort
    • 14.3.2. Lesaffre to acquire DSM-Firmenich's yeast extract business, boosting R&D and global expansion for savory ingredients
    • 14.3.3. Loopworm utilizes silkworms for sustainable animal protein source
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alpha Teknova, Inc.
  • 2. Becton, Dickinson and Company
  • 3. bioMerieux SA
  • 4. Biotecnica Inc.
  • 5. Corning Incorporated
  • 6. GE Healthcare
  • 7. HiMedia Laboratories
  • 8. Jinan Fengli Feed Co., Ltd
  • 9. Kerry Group plc
  • 10. Lonza Group Ltd.
  • 11. Merck KGaA
  • 12. MP Biomedicals, LLC
  • 13. Neogen Corporation
  • 14. Organotechnie SAS
  • 15. Promega Corporation
  • 16. Scharlab S.L.
  • 17. Solabia Group
  • 18. The Tatua Co-operative Dairy Company Ltd.
  • 19. Thermo Fisher Scientific Inc.
  • 20. Titan Biotech Ltd.
  • 21. VWR International, LLC
  • 22. ZymeFast Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦